Vorsitz: S. Dimmeler (Frankfurt am Main), D. Hassel (Heidelberg)
| (V23) | No correlation of miRNA-21, -133a, -26a and -29b with total collagen content in terminal failing human hearts supported by ventricular assist devices | |
| A. Kassner, C. Oezpeker, M. Morshuis, E. Rehn, J. Gummert, H. Milting (Bad Oeynhausen) | ||
| Diskussion | ||
| (V24) | MicroRNA based therapy to treat doxorubicin-mediated cardiotoxicity | |
| S. K. Gupta, K. Zimmer, P. Avramopoulos, S. Batkai, S. Engelhardt, K. Streckfuß-Bömeke, T. Thum (Hannover, Munich, Göttingen) | ||
| Diskussion | ||
| (V25) | Activation of MicroRNA-208b Promotes Maladaptive Cardiac Remodeling in Dilated Cardiomyopathy | |
| Q. Zhou, S. Schötterl, E. C. Brunner, R. Kandolf, M. Gawaz, M. Gramlich (Tübingen) | ||
| Diskussion | ||
| (V26) | miRNA-132 inhibition improves hypertrophy induced cardiomyopathy in pigs | |
| S. Straub, R. Hinkel, S. Batkai, A. Howe, K. Klett, R. Kozlik-Feldmann, F. Freudenthal, T. Thum, C. Kupatt (München, Hannover, Hamburg; La Paz, BO) | ||
| Diskussion | ||
| (V27) | Cardiomyocyte miR-29 promotes cardiac remodeling |
|
| Y. Sassi, P. Avramopoulos, D. P. Ramanujam, L. Grüter, S. Werfel, A. Papadopoulou, R. Kumarswamy, N. Hübner, B. de Stooper, M. Mayr, T. Thum, S. Engelhardt (München, Hannover, Berlin; Leuven, BE; London, UK) | ||
| Diskussion | ||
| (V28) | Inhibition of the pro-fibrotic miR-21 improves outcome after acute myocardial infarction: results of a preclinical pig model | |
| R. Hinkel, D. P. Ramanujam, V. Kaczmarekt, K. Klett, A. Howe, S. Engelhardt, C. Kupatt (München) | ||
| Diskussion |